1: Biochem Pharmacol. 2007 Dec 3;74(11):1587-95. Epub 2007 Aug...

1: Biochem Pharmacol. 2007 Dec 3;74(11):1587-95. Epub 2007 Aug 19. Links
The antiproliferative effects of phenoxodiol are associated with inhibition of plasma membrane electron transport in tumour cell lines and primary immune cells.Herst PM, Petersen T, Jerram P, Baty J, Berridge MV.
Malaghan Institute of Medical Research, P.O. Box 7060, Wellington 6005, New Zealand.

Although the redox-active synthetic isoflavene, phenoxodiol, is in Phase 3 clinical trials for drug-resistant ovarian cancer, and in early stage clinical trials for prostate and cervical cancer, its primary molecular target is unknown. Nevertheless, phenoxodiol inhibits proliferation of many cancer cell lines and induces apoptosis by disrupting FLICE-inhibitory protein, FLIP, expression and by caspase-dependent and -independent degradation of the X-linked inhibitor of apoptosis, XIAP. In addition, phenoxodiol sensitizes drug-resistant tumour cells to anticancer drugs including paclitaxel, carboplatin and gemcitabine. Here, we investigate the effects of phenoxodiol on plasma membrane electron transport (PMET) and cell proliferation in human leukemic HL60 cells and mitochondrial gene knockout HL60rho(o) cells that exhibit elevated PMET. Phenoxodiol inhibited PMET by both HL60 (IC(50) 32 microM) and HL60rho(o) (IC(50) 70 microM) cells, and this was associated with inhibition of cell proliferation (IC(50) of 2.8 and 6.7 microM, respectively), pan-caspase activation and apoptosis. Unexpectedly, phenoxodiol also inhibited PMET by activated murine splenic T cells (IC(50) of 29 microM) as well as T cell proliferation (IC(50) of 2.5 microM). In contrast, proliferation of WI-38 cells and HUVECs was only weakly affected by phenoxodiol. These results indicate that PMET may be a primary target for phenoxodiol in tumour cells and in activated T cells.

PMID: 17904534 [PubMed - indexed for MEDLINE]

Related articles
ECTO-NOX target for the anticancer isoflavene phenoxodiol. Oncol Res. 2007; 16(7):299-312.
[Oncol Res. 2007]
Molecular mechanism of phenoxodiol-induced apoptosis in ovarian carcinoma cells. Cancer. 2006 Feb 1; 106(3):599-608.
[Cancer. 2006]
Phenoxodiol--an isoflavone analog--induces apoptosis in chemoresistant ovarian cancer cells. Oncogene. 2003 May 1; 22(17):2611-20.
[Oncogene. 2003]
ReviewPlasma membrane electron transport: a new target for cancer drug development. Curr Mol Med. 2006 Dec; 6(8):895-904.
[Curr Mol Med. 2006]
ReviewPhenoxodiol: isoflavone analog with antineoplastic activity. Curr Oncol Rep. 2006 Mar; 8(2):104-7.
[Curr Oncol Rep. 2006]
» See reviews... | » See all...